Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mucosal Barrier of the Stomach

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...

Vaccinations

Vaccinations

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.

Humoral Immune Responses

Humoral Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.

Annals of the rheumatic diseases·2025

Same author

RSV Monitoring in Germany: A Critical Overview of Available Surveillance Systems.

Journal of clinical medicine·2025

Same author

Klinische Padiatrie·2022

Same author

Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany.

Frontiers in medicine·2021

Same author

Risk Factors for Complicated Lymphadenitis Caused by Nontuberculous Mycobacteria in Children.

Emerging infectious diseases·2020

Same author

Therapy of 645 children with parapneumonic effusion and empyema-A German nationwide surveillance study.

Pediatric pulmonology·2016

Same journal

Estimating clinical and economic impacts and cost-effectiveness of introducing 20-valent pneumococcal conjugate vaccine in Taiwan's pediatric National Immunization Program and impacts of a delayed implementation.

Human vaccines & immunotherapeutics·2026

Same journal

Safety and immunogenicity of a COVID-19-Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trial.

Human vaccines & immunotherapeutics·2026

Same journal

Randomized controlled trial evaluating immunogenicity and safety of a porcine circovirus-free rotavirus vaccine in healthy Chinese infants.

Human vaccines & immunotherapeutics·2026

Same journal

Determinants of HPV vaccination acceptance among young adult women in Japan's catch-up generation: A cross-sectional study.

Human vaccines & immunotherapeutics·2026

Same journal

Spatial accessibility analysis of vaccination units in Gansu Province, China (2025).

Human vaccines & immunotherapeutics·2026

Same journal

Pneumococcal vaccination awareness and uptake among high-risk patients attending internal medicine outpatient clinics: A cross-sectional study.

Human vaccines & immunotherapeutics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 20, 2026

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Mucosal immunization in perspective.

Markus A Rose¹

¹a Goethe University; Frankfurt, Germany.

Human Vaccines & Immunotherapeutics

|November 27, 2014

Summary

This summary is machine-generated.

Intranasal influenza vaccines offer a promising alternative to traditional shots, providing comparable or better protection directly in the respiratory tract. This easy, painless method could simplify mass immunization efforts against influenza.

Keywords:

diarrhea gastroenteritis mucosal pediatric immunization rota-virus

More Related Videos

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Related Experiment Videos

Last Updated: Apr 20, 2026

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Area of Science:

Immunology
Vaccinology
Public Health

Background:

Influenza viruses pose a significant global health risk, causing widespread illness and death.
Current influenza vaccines are mostly administered parenterally, despite infections occurring at mucosal surfaces.
Novel vaccine delivery methods targeting mucosal surfaces are being explored.

Purpose of the Study:

To evaluate the potential of intranasal influenza vaccines as a viable alternative to parenteral vaccination.
To compare the immunogenicity and efficacy of intranasal versus intramuscular influenza vaccination.
To assess the advantages of intranasal administration for mass immunization.

Main Methods:

Clinical studies comparing intranasal live attenuated influenza vaccine (LAIV) with intramuscular vaccination.
Assessment of immunogenicity and efficacy in the upper and lower respiratory tracts.

Main Results:

Intranasal LAIV demonstrated equivalent or superior immunogenicity and efficacy compared to intramuscular vaccination.
Intranasal administration proved to be an easy and painless method of delivery.
The approach facilitates mass immunization campaigns due to its non-sterile and simple application.

Conclusions:

Intranasal influenza vaccination is a viable and potentially superior approach to parenteral vaccination.
The ease of administration and efficacy make intranasal vaccines highly suitable for widespread public health initiatives.
Further development and implementation of intranasal influenza vaccines could significantly improve disease control.